Applied Biochemistry and Microbiology
Evidence-Based Tapering Schedules and Discontinuation Timelines There is no universal weaning protocoltapering depends on which GLP-1 medication you are taking, dose strength, treatment duration, and your individual health status
Nanotechnology for virus treatment
In a review of NAC usage in psychiatric and neurologic disorders, the most common dosages were 20002400 mg/day, which were generally well tolerated with low incidence of serious adverse effects (Slattery et al
Zbren P, Shah JP, Randolph GW, Silver CE, Olsen KD, Shaha AR, Zafereo ME , Kowalski LP, Suarez C, Sanabria A, Vander Poorten V, Nixon I, Rinaldo A, Ferlito A
The preclinical studies showed that GLP-1 analogs may have various anti-inflammatory effects on human fibroblast-like synoviocytes